Investigation of the tolerability of FOLFIRINOX in patients with unresectable advanced pancreatic cancer: Single-institution experience in Japan

被引：1
|
作者：
Miyashita, Kouichirou
Sekikawa, Takashi
Shimada, Ken
Yamamoto, Taikan
Kaga, Yasuhiro
Nunoue, Toshikazu
Uto, Yu
Kitahara, Yu
Hisamatsu, Atsushi
Saito, Yusuke
Kobayashi, Kouji
Takinishi, Yasutaka
Kinugasa, Eriko
机构：
[1] Showa Univ, Northern Yokohama Hosp, Internal Med Gastroenterol, Yokohama, Kanagawa, Japan
[2] Tokyo Cooperat Oncol Grp, Tokyo, Japan
[3] Showa Univ, Northern Yokohama Hosp, Yokohama, Kanagawa, Japan
[4] Showa Univ, Northern Yokohama Hosp, Internal Med Gastroenterol, Yokohama, Japan
[5] Showa Univ, Northern Yokohama Hosp, Kanagawa, Japan
[6] Showa Univ, Northern Yokohama Hosp, Dept Internal Med, Yokohama, Kanagawa, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.487
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
487
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Single-institution experience with FOLFIRINOX in advanced pancreatic cancer (PC)
    Gunturu, Krishna Soujanya
    Thumar, Jaykumar Ranchodbhai
    Hochster, Howard S.
    Stein, Stacey
    Yao, Xiaopan
    Cong, Xiangyu
    Hahn, Carol
    Kaley, Kristin
    Lacy, Jill
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [2] Single institution experience with FOLFIRINOX in advanced pancreatic cancer (PC)
    Gunturu, Krishna Soujanya
    Thumar, Jaykumar Ranchodbhai
    Hochster, Howard S.
    Stein, Stacey
    Yao, Xiaopan
    Cong, Xiangyu
    Lacy, Jill
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution experience
    Stroppa, E. M.
    Orlandi, E.
    Vecchia, S.
    Bodini, F. C.
    Zaffignani, E.
    Riva, A.
    Cavanna, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Institution experience of FOLFIRINOX chemotherapy in advanced pancreatic cancer
    Haddadin, Y.
    Herbertson, R.
    Webb, A.
    Selvadurai, E.
    Robinson, A.
    Cornah, I.
    ANNALS OF ONCOLOGY, 2016, 27 : 54 - 54
  • [5] Gemcitabine and mitomycin C in advanced pancreatic cancer: a single-institution experience
    Tuinmann, G
    Hegewisch-Becker, S
    Zschaber, R
    Kehr, A
    Schulz, J
    Hossfeld, DK
    ANTI-CANCER DRUGS, 2004, 15 (06) : 575 - 579
  • [6] Retrospective review of FOLFIRINOX in local advanced pancreatic cancer: Single institution experience.
    Manne, Ashish
    Reddy, Sushanth
    Heslin, Martin
    Jacob, Rojymon
    Vickers, Selwyn M.
    Contreras, Carlo M.
    Kasi, Anup
    Christein, John
    Li, Peng
    Posey, James
    Paluri, Ravi Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Outcomes of neoadjuvant chemotherapy with FOLFOX/FOLFIRINOX and chemoradiotherapy in borderline resectable pancreatic cancer: Single-institution experience
    Son, Chang O.
    Pai, Sachin Gopalkrishn
    Satti, Suma
    Dornelles, Adriana
    Bolton, John S.
    Conway, W. Charles
    Fuloria, Jyotsna
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [8] Definitive chemoradiation with full-dose gemcitabine for unresectable pancreatic cancer: A single-institution experience
    Zhou, Jessica
    Shen, Jincheng
    Schipper, Matthew J.
    Lawrence, Theodore Steven
    Feng, Mary Uan-Sian
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [9] Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution Experience
    Glicksman, Rachel M.
    Chung, Hans
    Myrehaug, Sten
    Erler, Darby
    Korol, Renee
    Karotki, Aliaksandr
    Taggar, Aman
    Ung, Yee C.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (09)
  • [10] 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience
    Winter, Jordan M.
    Cameron, John L.
    Campbell, Kurtis A.
    Arnold, Meghan A.
    Chang, David C.
    Coleman, JoAnn
    Hodgin, Mary B.
    Sauter, Patricia K.
    Hruban, Ralph H.
    Riall, Taylor S.
    Schulick, Richard D.
    Choti, Michael A.
    Lillemoe, Keith D.
    Yeo, Charles J.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2006, 10 (09) : 1199 - 1210
12345